ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
125.246,55
0,51%
S&P 500
6.033,84
0,59%
US Dollar vs BRL
5,9892
-0,44%
Bitcoin
98.043,42
2,49%
Brent Oil
72,865
0,26%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Heron Therapeautics Inc (HRTX)

  7. Heron Therapeautics Inc (HRTX) Notícias

HRTX

Heron Therapeautics (HRTX)

Heron Therapeautics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:HRTX
DataHoraFonteTítuloCódigoCompanhia
12/11/202410:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HRTXHeron Therapeautics Inc
12/11/202409:55PR Newswire (US)Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial GuidanceNASDAQ:HRTXHeron Therapeautics Inc
06/11/202416:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
05/11/202414:41Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
04/11/202419:00PR Newswire (US)Heron Therapeutics Announces Appointment of Michael Kaseta to Board of DirectorsNASDAQ:HRTXHeron Therapeautics Inc
29/10/202417:05PR Newswire (US)Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024NASDAQ:HRTXHeron Therapeautics Inc
24/10/202415:02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:HRTXHeron Therapeautics Inc
10/10/202417:08PR Newswire (US)Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®, and APONVIE® as Alternatives During the Potential Shortage of Intravenous FluidsNASDAQ:HRTXHeron Therapeautics Inc
25/09/202409:00PR Newswire (US)Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")NASDAQ:HRTXHeron Therapeautics Inc
03/09/202409:00PR Newswire (US)Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business OfficerNASDAQ:HRTXHeron Therapeautics Inc
06/08/202417:35Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:HRTXHeron Therapeautics Inc
06/08/202417:05PR Newswire (US)Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial GuidanceNASDAQ:HRTXHeron Therapeautics Inc
30/07/202417:05PR Newswire (US)Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024NASDAQ:HRTXHeron Therapeautics Inc
15/07/202409:00PR Newswire (US)Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment SystemNASDAQ:HRTXHeron Therapeautics Inc
02/07/202409:00PR Newswire (US)Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")NASDAQ:HRTXHeron Therapeautics Inc
31/05/202412:08Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:HRTXHeron Therapeautics Inc
29/05/202409:05PR Newswire (US)Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")NASDAQ:HRTXHeron Therapeautics Inc
07/05/202409:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HRTXHeron Therapeautics Inc
07/05/202409:00PR Newswire (US)Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate UpdatesNASDAQ:HRTXHeron Therapeautics Inc
24/04/202409:00PR Newswire (US)Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024NASDAQ:HRTXHeron Therapeautics Inc
11/04/202417:05PR Newswire (US)Heron Therapeutics to Host Investor Day on May 15, 2024 in New York CityNASDAQ:HRTXHeron Therapeautics Inc
28/03/202417:05PR Newswire (US)Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:HRTXHeron Therapeautics Inc
13/03/202417:25AllPennyStocks.comBiotech Finds Mid-Week Success Following Q4 Earnings ReleaseNASDAQ:HRTXHeron Therapeautics Inc
12/03/202417:05PR Newswire (US)Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate UpdatesNASDAQ:HRTXHeron Therapeautics Inc
12/03/202408:22IH Market NewsGlobal Markets Await U.S. Inflation Report: Mixed Movements in Pre-Market TradingNASDAQ:HRTXHeron Therapeautics Inc
28/02/202410:00PR Newswire (US)Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024NASDAQ:HRTXHeron Therapeautics Inc
14/02/202418:37Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HRTXHeron Therapeautics Inc
24/01/202411:25AllPennyStocks.comPremarket Heats Up For Biotech Before Opening BellNASDAQ:HRTXHeron Therapeautics Inc
23/01/202422:00PR Newswire (US)Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue ProceduresNASDAQ:HRTXHeron Therapeautics Inc
07/01/202419:00PR Newswire (US)Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative PainNASDAQ:HRTXHeron Therapeautics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:HRTX

Seu Histórico Recente

BOV
COGN3
COGNA ON
BOV
IBOV
Índice Bovespa
BOV
ATOM3
ATOMPAR ON
BOV
PRIO3
PETRORIO ON
BOV
HAGA3
HAGA ON
BOV
AZEV4
AZEVEDO PN
BOV
RNEW4
RENOVA PN
BOV
BHIA3
Grupo Casas Bahia ON
BOV
AGXY3
Agrogalaxy Participacoes ON
BOV
PDGR3
PDG REALT ON
BOV
HBOR3
HELBOR ON
BOV
AMAR3
LOJAS MARISA ON
BOV
GFSA3
GAFISA ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
TELB4
TELEBRAS PN
BOV
AMER3
Americanas ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Economize até 50%* para TRADER BRASIL

1 ano 30%, 2 anos 40% e *3 anos 50%

*Ao longo de 3 anos $ 881.64 apenas $ 440.82